Differences in efficacy and safety of lubiprostone used for idiopathic vs opioid-induced constipation: meta-analysis of East Asian and Western populations

Clicks: 207
ID: 119308
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Several secretagogues, such as lubiprostone, have been developed for the treatment of constipation in the last 10 years. It is unclear whether the efficacy of lubiprostone for spontaneous bowel movement (SBM) and the adverse events are similar between idiopathic and opioid-induced constipation and b …
Reference Key
m2020journaldifferences Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sugimoto M;Murata M;Mizuno H;;
Journal journal of clinical biochemistry and nutrition
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32523244/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review pubmed abstract nih national institutes of health national library of medicine masaki murata mitsushige sugimoto hitomi mizuno pmid:32523244 pmc7263933 doi:10.3164/jcbn.19-118

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.